Endogenous ligands of TLR2 and TLR4: Agonists or assistants?

Journal of Leukocyte Biology

Volumn 87, Issue 6, 2010, Pages 989-999

  Erridge, Clett ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Alarmin; DAMP; Inflammation; Innate immunity; PAMP

Indexed keywords

CELL PROTEIN; ENDOTOXIN; LIPID; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; PROTEIN PAMP; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; LIGAND;

AUTOIMMUNITY; CHRONIC INFLAMMATION; HUMAN; INNATE IMMUNITY; NONHUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR; ANIMAL; DRUG POTENTIATION;

BACTERIA (MICROORGANISMS); MAMMALIA;

ANIMALS; HUMANS; LIGANDS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 77954005130     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1209775     Document Type: Review

References (130)

1. Kawai, T., Akira, S. (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21, 317-337.
2. Kawai, T., Akira, S. (2005) Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17, 338-344.
3. Tsan, M. F., Gao, B. (2004) Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76, 514-519.
4. Bianchi, M. E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5.
5. Wagner, H. (2006) Endogenous TLR ligands and autoimmunity. Adv. Immunol. 91, 159-173.
6. Gao, B., Tsan, M. F. (2003) Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor α from murine macrophages. J. Biol. Chem. 278, 22523-22529. (Pubitemid 36830307)
7. Bausinger, H., Lipsker, D., Ziylan, U., Manié, S., Briand, J. P., Cazenave, J. P., Muller, S., Haeuw, J. F., Ravanat, C., de la Salle, H., Hanau, D. (2002) Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32, 3708-3713. (Pubitemid 36032655)
8. Erridge, C., Samani, N. J. (2009) Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler. Thromb. Vasc. Biol. 29, 1944-1949.
9. Hreggvidsdottir, H. S., Ostberg, T., Wähämaa, H., Schierbeck, H., Aveberger, A. C., Klevenvall, L., Palmblad, K., Ottosson, L., Andersson, U., Harris, H. E. (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86, 655-662.
10. Youn, J. H., Oh, Y. J., Kim, E. S., Choi, J. E., Shin, J. S. (2008) High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-α production in human monocytes. J. Immunol. 180, 5067-5074.
11. Erridge, C., Webb, D. J., Spickett, C. M. (2007) Toll-like receptor 4 signaling is neither sufficient nor required for oxidized phospholipid mediated induction of interleukin-8 expression. Atherosclerosis 193, 77-85. (Pubitemid 46776713)
12. Gasic-Milenkovic, J., Dukic-Stefanovic, S., Deuther-Conrad, W., Gärtner, U., Münch, G. (2003) β-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -γ and "advanced glycation endproducts" in a murine microglia cell line. Eur. J. Neurosci. 17, 813-821. (Pubitemid 36315251)
13. Lotz, M., Ebert, S., Esselmann, H., Iliev, A. I., Prinz, M., Wiazewicz, N., Wiltfang, J., Gerber, J., Nau, R. (2005) Amyloid β peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Tolllike receptor-9-induced inflammation in primary mouse microglial cell cultures. J. Neurochem. 94, 289-298. (Pubitemid 40995245)
14. Krejcova, D., Pekarova, M., Safrankova, B., Kubala, L. (2009) The effect of different molecular weight hyaluronan on macrophage physiology. Neuroendocrinol. Lett. 30, 106-111.
15. Erridge, C. (2009) The roles of Toll-like receptors in atherosclerosis. J. Innate Immun. 1, 340-349.
16. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., Flier, J. S. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025. (Pubitemid 44684486)
17. Abdollahi-Roodsaz, S., Joosten, L. A., Roelofs, M. F., Radstake, T. R., Matera, G., Popa, C., van der Meer, J. W., Netea, M. G., van den Berg, W. B. (2007) Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 56, 2957-2967. (Pubitemid 47502742)
18. Vabulas, R. M., Ahmad-Nejad, P., Ghose, S., Kirschning, C. J., Issels, R. D., Wagner, H. (2002) HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277, 15107-15112. (Pubitemid 34952589)
19. Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Bare, O., Auron, P. E., Stevenson, M. A., Calderwood, S. K. (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028-15034. (Pubitemid 34952579)
20. De Graaf, R., Kloppenburg, G., Kitslaar, P. J., Bruggeman, C. A., Stassen, F. (2006) Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect. 8, 1859-1865. (Pubitemid 44128888)
21. Ohashi, K., Burkart, V., Flohe, S., Kolb, H. (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor- 4 complex. J. Immunol. 164, 558-561. (Pubitemid 30043672)
22. Li, M., Carpio, D. F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, R. M., Beg, A. A. (2001) An essential role of the NF-κ B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166, 7128-7135. (Pubitemid 32525583)
23. Lee, H., Jo, E. K., Choi, S. Y., Oh, S. B., Park, K., Kim, J. S., Lee, S. J. (2006) Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem. Biophys. Res. Commun. 350, 742-747. (Pubitemid 44566388)
24. Li, T., Wang, Y., Liu, C., Hu, Y., Wu, M., Li, J., Guo, L., Chen, L., Chen, Q., Ha, T., Li, C., Li, Y. (2009) MyD88-dependent nuclear factor-κB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes. J. Hypertens. 27, 1084-1093.
25. Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., Yang, H., Amigorena, S., Ryffel, B., Barrat, F. J., Saftig, P., Levi, F., Lidereau, R., Nogues, C., Mira, J. P., Chompret, A., Joulin, V., Clavel-Chapelon, F., Bourhis, J., André, F., Delaloge, S., Tursz, T., Kroemer, G., Zitvogel, L. (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13, 1050-1059.
26. Kim, H. S., Han, M. S., Chung, K. W., Kim, S., Kim, E., Kim, M. J., Jang, E., Lee, H. A., Youn, J., Akira, S., Lee, M. S. (2007) Toll-like receptor 2 senses β-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27, 321-333. (Pubitemid 47284922)
27. Curtin, J. F., Liu, N., Candolfi, M., Xiong, W., Assi, H., Yagiz, K., Edwards, M. R., Michelsen, K. S., Kroeger, K. M., Liu, C., Muhammad, A. K., Clark, M. C., Arditi, M., Comin-Anduix, B., Ribas, A., Lowenstein, P. R., Castro, M. G. (2009) HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med. 6, e10.
28. Park, J. S., Svetkauskaite, D., He, Q., Kim, J. Y., Strassheim, D., Ishizaka, A., Abraham, E. (2004) Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377. (Pubitemid 38294612)
29. Park, J. S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J. Y., Strassheim, D., Sohn, J. W., Yamada, S., Maruyama, I., Banerjee, A., Ishizaka, A., Abraham, E. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 290, C917-C924.
30. Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., Yang, H. (2006) HMGB1 signals through Tolllike receptor (TLR) 4 and TLR2. Shock 26, 174-179. (Pubitemid 44162504)
31. Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A., Nacken, W., Foell, D., van der Poll, T., Sorg, C., Roth, J. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13, 1042-1049. (Pubitemid 47517513)
32. Zhang, P., Cox, C. J., Alvarez, K. M., Cunningham, M. W. (2009) Cutting edge: cardiac myosin activates innate immune responses through TLRs. J. Immunol. 183, 27-31.
33. Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., Strauss III, J. F. (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229-10233.
34. Gondokaryono, S. P., Ushio, H., Niyonsaba, F., Hara, M., Takenaka, H., Jayawardana, S. T., Ikeda, S., Okumura, K., Ogawa, H. (2007) The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4. J. Leukoc. Biol. 82, 657-665. (Pubitemid 47367158)
35. Schaefer, L., Babelova, A., Kiss, E., Hausser, H. J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., Malle, E., Schaefer, R. M., Gröne, H. J. (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115, 2223-2233.
36. Babelova, A., Moreth, K., Tsalastra-Greul, W., Zeng-Brouwers, J., Eickelberg, O., Young, M. F., Bruckner, P., Pfeilschifter, J., Schaefer, R. M., Gröne, H. J., Schaefer, L. (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome via Toll-like and P2X receptors. J. Biol. Chem. 284, 24035-24048.
37. Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., Simon, J. C. (2002) Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195, 99-111. (Pubitemid 34074500)
38. Gariboldi, S., Palazzo, M., Zanobbio, L., Selleri, S., Sommariva, M., Sfondrini, L., Cavicchini, S., Balsari, A., Rumio, C. (2008) Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of β-defensin 2 via TLR2 and TLR4. J. Immunol. 181, 2103-2110.
39. Shimada, M., Yanai, Y., Okazaki, T., Noma, N., Kawashima, I., Mori, T., Richards, J. S. (2008) Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development 135, 2001-2011. (Pubitemid 351943364)
40. Taylor, K. R., Yamasaki, K., Radek, K. A., Di Nardo, A., Goodarzi, H., Golenbock, D., Beutler, B., Gallo, R. L. (2007) Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 282, 18265-18275. (Pubitemid 47100227)
41. Scheibner, K. A., Lutz, M. A., Boodoo, S., Fenton, M. J., Powell, J. D., Horton, M. R. (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177, 1272-1281. (Pubitemid 44036633)
42. Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., Homer, R. J., Goldstein, D. R., Bucala, R., Lee, P. J., Medzhitov, R., Noble, P. W. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11, 1173-1179.
43. Taylor, K. R., Trowbridge, J. M., Rudisill, J. A., Termeer, C. C., Simon, J. C., Gallo, R. L. (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279, 17079-17084.
44. Johnson, G. B., Brunn, G. J., Kodaira, Y., Platt, J. L. (2002) Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168, 5233-5239. (Pubitemid 34495991)
45. Johnson, G. B., Brunn, G. J., Platt, J. L. (2004) An endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J. Immunol. 172, 20-24.
46. Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., Brennan, F., Foxwell, B. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 15, 774-780.
47. Kim, S., Takahashi, H., Lin, W. W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J. L., Karin, M. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106.
48. Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., Witztum, J. L. (2003) Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2 and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278, 1561-1568. (Pubitemid 36801384)
49. Miller, Y. I., Viriyakosol, S., Worrall, D. S., Boullier, A., Butler, S., Witztum, J. L. (2005) Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler. Thromb. Vasc. Biol. 25, 1213-1219. (Pubitemid 40776611)
50. Bae, Y. S., Lee, J. H., Choi, S. H., Kim, S., Almazan, F., Witztum, J. L., Miller, Y. I. (2008) Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein. Toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ. Res. 104, 210-218.
51. Walton, K. A., Hsieh, X., Gharavi, N., Wang, S., Wang, G., Yeh, M., Cole, A. L., Berliner, J. A. (2003) Receptors involved in the oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8: a role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 278, 29661-29668.
52. Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., Liu, H., Sun, Y., Pasparakis, M., Kopf, M., Mech, C., Bavari, S., Peiris, J. S. M., Slutsky, A. S., Akira, S., Hultqvist, M., Holmdahl, R., Nicholls, J., Jiang, C., Binder, C. J., Penninger, J. M. (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235-249.
53. Bianchi, M. E. (2009) HMGB1 loves company. J. Leukoc. Biol. 86, 573-576.
54. Hodgkinson, C. P., Laxton, R. C., Patel, K., Ye, S. (2008) Advanced glycation end-product of low density lipoprotein activates the Toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28, 2275-2281.
55. Guillot, L., Balloy, V., McCormack, F. X., Golenbock, D. T., Chignard, M., Si-Tahar, M. (2002) Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168, 5989-5992. (Pubitemid 34620010)
56. Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K., Farber, J. M., Segal, D. M., Oppenheim, J. (2002) Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298, 1025-1029. (Pubitemid 35247310)
57. Funderburg, N., Lederman, M. M., Feng, Z., Drage, M. G., Jadlowsky, J., Harding, C. V., Weinberg, A., Sieg, S. F. (2007) Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. USA 104, 18631-18635. (Pubitemid 350210748)
58. Biragyn, A., Coscia, M., Nagashima, K., Sanford, M., Young, H. A., Olkhanud, P. (2008) Murine β-defensin 2 promotes TLR-4/MyD88-mediated and NF-κB-dependent atypical death of APCs via activation of TNFR2. J. Leukoc. Biol. 83, 998-1008. (Pubitemid 351959881)
59. Senn, J. J. (2006) Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J. Biol. Chem. 281, 26865-26875.
60. Nguyen, M. T., Favelyukis, S., Nguyen, A. K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., Olefsky, J. M. (2007) A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282, 35279-35292. (Pubitemid 350232441)
61. Schaeffler, A., Gross, P., Buettner, R., Bollheimer, C., Buechler, C., Neumeier, M., Kopp, A., Schoelmerich, J., Falk, W. (2008) Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-κB pathway in adipocytes links nutritional signaling with innate immunity. Immunology 126, 233-245.
62. Lee, J. Y., Plakidask, A., Lee, W. H., Heikkinen, A., Chanmugam, P., Bray, G., Hwang, D. H. (2003) Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 44, 479-486. (Pubitemid 37279695)
63. Lee, J. Y., Ye, J., Gao, Z., Youn, H. S., Lee, W. H., Zhao, L., Sizemore, N., Hwang, D. H. (2003) Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/ AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 278, 37041-37051. (Pubitemid 37175218)
64. Lee, J. Y., Zhao, L., Youn, H. S., Weatherill, A. R., Tapping, R., Feng, L., Lee, W. H., Fitzgerald, K. A., Hwang, D. H. (2004) Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 279, 16971-16979. (Pubitemid 38560450)
65. Lee, J. Y., Sohn, K. H., Rhee, S. H., Hwang, D. (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase- 2 mediated through Toll-like receptor 4. J. Biol. Chem. 276, 16683-16689.
66. Weatherill, A. R., Lee, J. Y., Zhao, L., Lemay, D. G., Youn, H. S., Hwang, D. H. (2005) Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 174, 5390-5397. (Pubitemid 40593178)
67. Suganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., Mizuarai, S., Kotani, H., Yamaoka, S., Miyake, K., Aoe, S., Kamei, Y., Ogawa, Y. (2007) Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27, 84-91.
68. Radin, M. S., Sinha, S., Bhatt, B. A., Dedousis, N., O'Doherty, R. M. (2007) Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 51, 336-346.
69. Smiley, S. T., King, J. A., Hancock, W. W. (2001) Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167, 2887-2894.
70. Hodgkinson, C. P., Patel, K., Ye, S. (2008) Functional Toll-like receptor 4 mutations modulate the response to fibrinogen. Thromb. Haemost. 100, 301-307.
71. Kuhns, D. B., Priel, D. A., Gallin, J. I. (2007) Induction of human monocyte interleukin (IL)-8 by fibrinogen through the Toll-like receptor pathway. Inflammation 30, 178-188.
72. Banas, M. C., Banas, B., Hudkins, K. L., Wietecha, T. A., Iyoda, M., Bock, E., Hauser, P., Pippin, J. W., Shankland, S. J., Smith, K. D., Stoelcker, B., Liu, G., Gröne, H. J., Krämer, B. K., Alpers, C. E. (2008) TLR4 links podocytes with the innate immune system to mediate glomerular injury. J. Am. Soc. Nephrol. 19, 704-713.
73. He, R. L., Zhou, J., Hanson, C. Z., Chen, J., Cheng, N., Ye, R. D. (2009) Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 113, 429-437.
74. Cheng, N., He, R., Tian, J., Ye, P. P., Ye, R. D. (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 181, 22-26.
75. Sandri, S., Rodriguez, D., Gomes, E., Monteiro, H. P., Russo, M., Campa, A. (2008) Is serum amyloid A an endogenous TLR4 agonist? J. Leukoc. Biol. 83, 1174-1180. (Pubitemid 351960349)
76. Satta, N., Dunoyer-Geindre, S., Reber, G., Fish, R. J., Boehlen, F., Kruithof, E. K. O., de Moerloose, P. (2007) The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 109, 1507-1514. (Pubitemid 46239583)
77. Tü kel, C., Wilson, R. P., Nishimori, J. H., Pezeshki, M., Chromy, B. A., Bäumler, A. J. (2009) Responses to amyloids of microbial and host origin are mediated through Toll-like receptor 2. Cell Host Microbe 6, 45-53.
78. Ji, Y. Y., Liu, J. T., Liu, N., Wang, Z. D., Liu, C. H. (2009) PPARα activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway. Biochem. Pharmacol. 78, 1186-1197.
79. Ji, Y., Liu, J., Wang, Z., Liu, N. (2009) Angiotensin II induces inflammatory response partly via Toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell. Physiol. Biochem. 23, 265-276.
80. Tsan, M. F., Gao, B. (2007) Review: pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J. Endotoxin Res. 13, 6-14.
81. Taylor, K. E., Giddings, J. C., van den Berg, C. W. (2005) C-reactive protein-induced in vitro endothelial cell activation is an artifact caused by azide and lipopolysaccharide. Arterioscler. Thromb. Vasc. Biol. 25, 1225-1230.
82. Uphoff, C. C., Drexler, H. G. (2002) Comparative PCR analysis for detection of mycoplasma infections in continuous cell lines. In Vitro Cell. Dev. Biol. Anim. 38, 79-85. (Pubitemid 34538199)
83. Lichtnekert, J., Vielhauer, V., Zecher, D., Kulkarni, O. P., Clauss, S., Segerer, S., Hornung, V., Mayadas, T. N., Beutler, B., Akira, S., Anders, H. J. (2009) Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/ Trif. Am. J. Physiol. Renal Physiol. 296, F867-F874.
84. Serke, H., Vilser, C., Nowicki, M., Hmeidan, F. A., Blumenauer, V., Hummitzsch, K., Lösche, A., Spanel-Borowski, K. (2009) Granulosa cell subtypes respond by autophagy or cell death to oxLDL-dependent activation of the oxidized lipoprotein receptor 1 and Toll-like 4 receptor. Autophagy 5, 991-1003.
85. Dentener, M. A., Von Asmuth, E. J., Francot, G. J., Marra, M. N., Buurman, W. A. (1993) Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide- induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. J. Immunol. 151, 4258-4265.
86. Cavaillon, J. M., Haeffner-Cavaillon, N. (1986) Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin. Mol. Immunol. 23, 965-969.
87. Glorieux, G., Schepers, E., Schindler, R., Lemke, H. D., Verbeke, F., Dhondt, A., Lameire, N., Vanholder, R. (2009) A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test. Nephrol. Dial. Transplant. 24, 548-554.
88. Daneshian, M., von Aulock, S., Hartung, T. (2009) Assessment of pyrogenic contaminations with validated human whole-blood assay. Nat. Protoc. 4, 1709-1721.
89. Feingold, K. R., Funk, J. L., Moser, A. H., Shigenaga, J. K., Rapp, J. H., Grunfeld, C. (1995) Role for circulating lipoproteins in protection from endotoxin toxicity. Infect. Immun. 63, 2041-2046.
90. Navab, M., Hough, G. P., Van Lenten, B. J., Berliner, J. A., Fogelman, A. M. (1988) Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form. J. Clin. Invest. 81, 601-605. (Pubitemid 18075257)
91. Habich, C., Kempe, K., van der Zee, R., Rümenapf, R., Akiyama, H., Kolb, H., Burkart, V. (2005) Heat shock protein 60: specific binding of lipopolysaccharide. J. Immunol. 174, 1298-1305.
92. Stamme, C., Mü ller, M., Hamann, L., Gutsmann, T., Seydel, U. (2002) Surfactant protein A inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide- binding protein. Am. J. Respir. Cell Mol. Biol. 27, 353-360.
93. Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S. L., Ganz, T., Selsted, M. E. (1989) Interaction of human defensins with Escherichia coli. J. Clin. Invest. 84, 553-561.
94. Motzkus, D., Schulz-Maronde, S., Heitland, A., Schulz, A., Forssmann, W. G., Jübner, M., Maronde, E. (2006) The novel β-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. FASEB J. 20, 1701-1702.
95. Campbell, I. D., Spitzfaden, C. (1994) Building proteins with fibronectin type III modules. Structure 2, 333-337.
96. Bell, J. K., Mullen, G. E., Leifer, C. A., Mazzoni, A., Davies, D. R., Segal, D. M. (2003) Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 24, 528-533. (Pubitemid 37205203)
97. Wu, F., Vij, N., Roberts, L., Lopez-Briones, S., Joyce, S., Chakravarti, S. (2007) A novel role of the lumican core protein in bacterial lipopolysaccharide- induced innate immune response. J. Biol. Chem. 282, 26409-26417. (Pubitemid 47443780)
98. Courtney, H. S., Simpson, W. A., Beachey, E. H. (1983) Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin. J. Bacteriol. 153, 763-770.
99. Wight, T. N., Merrilees, M. J. (2004) Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 94, 1158-1167.
100. Bouzidi, F., Doussiere, J. (2004) Binding of arachidonic acid to myeloid-related proteins (S100A8/A9) enhances phagocytic NADPH oxidase activation. Biochem. Biophys. Res. Commun. 325, 1060-1065. (Pubitemid 39487978)
101. Shah, C., Hari-Dass, R., Raynes, J. G. (2006) Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108, 1751-1757. (Pubitemid 44316146)
102. Liang, O. D., Ascencio, F., Fransson, L. A., Wadström, T. (1992) Binding of heparan sulfate to Staphylococcus aureus. Infect. Immun. 60, 899-906.
103. Osterloh, A., Kalinke, U., Weiss, S., Fleischer, B., Breloer, M. (2007) Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide. J. Biol. Chem. 282, 4669-4680. (Pubitemid 47100986)
104. Bortolussi, R., Rajaraman, K., Qing, G., Rajaraman, R. (1997) Fibronectin enhances in vitro lipopolysaccharide priming of polymorphonuclear leukocytes. Blood 89, 4182-4189. (Pubitemid 27220968)
105. Ribes, S., Ebert, S., Regen, T., Czesnik, D., Scheffel, J., Zeug, A., Bunkowski, S., Eiffert, H., Hanisch, U. K., Hammerschmidt, S., Nau, R. (2010) Fibronectin stimulates Escherichia coli phagocytosis by microglial cells. Glia 58, 367-376.
106. Campo, G. M., Avenoso, A., Campo, S., D'Ascola, A., Nastasi, G., Calatroni, A. (2009) Molecular size hyaluronan differently modulates Tolllike receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie, Epub ahead of print.
107. Jürgens, G., Mü ller, M., Garidel, P., Koch, M. H., Nakakubo, H., Blume, A., Brandenburg, K. (2002) Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A. J. Endotoxin Res. 8, 115-126.
108. Nakatomi, K., Aida, Y., Kusumoto, K., Pabst, M. J., Maeda, K. (1998) Neutrophils responded to immobilized lipopolysaccharide in the absence of lipopolysaccharide-binding protein. J. Leukoc. Biol. 64, 177-184. (Pubitemid 28354979)
109. Ikeda, K., Matsuzaki, K. (2008) Driving force of binding of amyloid β-protein to lipid bilayers. Biochem. Biophys. Res. Commun. 370, 525-529.
110. Pugin, J., Schurer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J., Tobias, P. S. (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90, 2744-2748. (Pubitemid 23113493)
111. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., Mathison, J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249, 1431-1433.
112. Schroder, N. W. J., Heine, H., Alexander, C., Manukyan, M., Eckert, J., Hamann, L., Gobel, U. B., Schumann, R. R. (2004) Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J. Immunol. 173, 2683-2691. (Pubitemid 39063129)
113. Sellati, T. J., Bouis, D. A., Kitchens, R. L., Darveau, R. P., Pugin, J., Ulevitch, R. J., Gangloff, S. C., Goyert, S. M., Norgard, M. V., Radolf, J. D. (1998) Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J. Immunol. 160, 5455-5464. (Pubitemid 28267837)
114. Erridge, C., Kennedy, S., Spickett, C. M., Webb, D. J. (2008) Oxidized phospholipid inhibition of Toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4 - roles for CD14, LPS-binding protein and MD2 as targets for specificity of inhibition. J. Biol. Chem. 283, 24748-24759.
115. Li, W., Sama, A. E., Wang, H. (2006) Role of HMGB1 in cardiovascular diseases. Curr. Opin. Pharmacol. 6, 130-135.
116. Tan, M. H., Sun, Z., Opitz, S. L., Schmidt, T. E., Peters, J. H., George, E. L. (2004) Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 104, 11-18. (Pubitemid 38879830)
117. Kol, A., Bourcier, T., Lichtman, A. H., Libby, P. (1999) Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells and macrophages. J. Clin. Invest. 103, 571-577. (Pubitemid 29094058)
118. Dunzendorfer, S., Lee, H. K., Soldau, K., Tobias, P. S. (2004) Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J. 18, 1117-1119. (Pubitemid 39561542)
119. Wiedermann, C. J., Kiechl, S., Dunzendorfer, S., Schratzberger, P., Egger, G., Oberhollenzer, F., Willeit, J. (1999) Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study. J. Am. Coll. Cardiol. 34, 1975-1981. (Pubitemid 30002653)
120. Pussinen, P. J., Tuomisto, K., Jousilahti, P., Havulinna, A. S., Sundvall, J., Salomaa, V. (2007) Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler. Thromb. Vasc. Biol. 27, 1433-1439. (Pubitemid 46809435)
121. Erridge, C., Attina, T., Spickett, C. M., Webb, D. J. (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86, 1286-1292. (Pubitemid 350126229)
122. Bhanji, S., Williams, B., Sheller, B., Elwood, T., Mancl, L. (2002) Transient bacteremia induced by toothbrushing a comparison of the Sonicare toothbrush with a conventional toothbrush. Pediatr. Dent. 24, 295-299.
123. Silver, J. G., Martin, A. W., McBride, B. C. (1977) Experimental transient bacteremias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J. Clin. Periodontol. 4, 92-99.
124. Van der Heijden, I. M., Wilbrink, B., Tchetverikov, I., Schrijver, I. A., Schouls, L. M., Hazenberg, M. P., Breedveld, F. C., Tak, P. P. (2000) Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 43, 593-598. (Pubitemid 30394951)
125. Gerard, H. C., Wang, Z., Wang, G. F., El-Gabalawy, H., Goldbach-Mansky, R., Li, Y., Majeed, W., Zhang, H., Ngai, N., Hudson, A. P., Schumacher, H. R. (2001) Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum. 44, 1689-1697. (Pubitemid 32642232)
126. Ott, S. J., El Mokhtari, N. E., Musfeldt, M., Hellmig, S., Freitag, S., Rehman, A., Kuhbacher, T., Nikolaus, S., Namsolleck, P., Blaut, M., Hampe, J., Sahly, H., Reinecke, A., Haake, N., Gunther, R., Kruger, D., Lins, M., Herrmann, G., Folsch, U. R., Simon, R., Schreiber, S. (2006) Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113, 929-937.
127. Erridge, C., Burdess, A., Jackson, A. J., Murray, C., Riggio, M., Lappin, D., Milligan, S., Spickett, C. M., Webb, D. J. (2008) Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma. Eur. J. Clin. Invest. 38, 713-720.
128. Juvonen, J., Juvonen, T., Laurila, A., Alakarppa, H., Lounatmaa, K., Surcel, H. M., Leinonen, M., Kairaluoma, M. I., Saikku, P. (1997) Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurisms. J. Vasc. Surg. 25, 499-505. (Pubitemid 27136974)
129. Laman, J. D., Schoneveld, A. H., Moll, F. L., van Meurs, M., Pasterkamp, G. (2002) Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am. J. Cardiol. 90, 119-123.
130. Yang, H. Z., Cui, B., Liu, H. Z., Mi, S., Yan, J., Yan, H. M., Hua, F., Lin, H., Cai, W. F., Xie, W. J., Lv, X. X., Wang, X. X., Xin, B. M., Zhan, Q. M., Hu, Z. W. (2009) Blocking TLR2 activity attenuates pulmonary metastases of tumor. PLoS One 4, e6520.